Revealing what others leave unseen: The future of ion mobility has arrived
15 Jun 2021

MOBILion Systems is disrupting the separations game, enhancing the way we characterize biotherapeutics and identify biomarkers.

Existing separation technologies often lack the resolution and throughput that pharmaceutical and clinical researchers need. MOBILion’s High-Resolution Ion Mobility Mass Spectrometry (HRIM-MS) platform enables separation and identification of the most challenging molecules with unprecedented resolution. Leveraging a 13-meter ion mobility path length to provide deeper level characterization without compromising time or reproducibility. Enable fast, efficient separation and identification of molecules other instruments fail to detect.

Join us for the virtual product launch of MOBILion’s HRIM-MS platform featuring presentations by early adopters and beta users of this best in class separations technology. including Prof. John McLean, Vanderbilt University, Dr. Jared Auclair, Northeastern University and scientists from Protein Metrics. Learn how this best-in-class separations technology promises to fill characterization gaps, bring biologic drugs to market faster and accelerate biomarker discoveries.

Who should attend:

  • Scientists seeking deeper-level characterization of biotherapeutics
  • Scientists requiring better separation of complex and challenging molecules
  • Researchers looking for potential disease biomarkers
  • Researchers seeking rapid and reproducible methods of characterizing large-scale sample sets

Presentation 1: Revealing what others leave unseen: Introducing MOBILion’s new high-resolution ion mobility mass spectrometry platform

MOBILion’s high-resolution ion mobility mass spectrometry (HRIM-MS) platform is designed to enable the separation and identification of the most challenging molecules with unprecedented resolution.

This virtual product launch will feature live footage from MOBILion’s HRIM-MS instrument release event along with testimonials from current users of this new separations technology.

Presentation 2: Complex protein workflow solutions with Protein Metrics

In January 2021, MOBILion and Protein Metrics joined forces to deliver on the promise of eliminating impediments to identifying and characterizing critical quality attributes(CQAs) with the reliability, repeatability and speed required in modern biopharmaceutical organizations developing more complex protein therapeutics.

This session will present workflow solutions that aim to combine the fastest, highest resolution, most reproducible therapeutic protein analysis with simple, automated data analysis and visualization.

Presentation 3: Mappingbiology at high resolution: Molecular phenomics in systems, synthetic, andchemical biology

One of the predominant challenges in systems-wide analyses and molecular phenomics is the broad-scale characterization of the molecular inventory in cells, tissues, and biological fluids.

Advances in computational systems biology rely heavily on the experimental capacity to make omics measurements, i.e., integrated metabolomics, proteomics, lipidomics, glycomics, etc., accompanied with fast minimal sample preparation, high resolving power in separation dimensions, rapid measurements, high concentration dynamic range, low limits of detection, and high selectivity.

This confluence of figures-of-merit places demanding challenges on analytical platforms for such analyses. Ion mobility-mass spectrometry (IM-MS) provides rapid gas-phase electrophoretic separations on the basis of molecular structure and is well suited for integration with rapid mass spectrometry detection techniques. Advances in the resolving power of the ion mobility dimension, coupled with enhanced accuracy and precision, are opening new directions for integrating these data into molecular phenomic workflows, with a special emphasis on lipidomics.

In this webinar, Prof. John McLean, Vanderbilt University, will discuss new advances in bioinformatics and biostatistics and how they can be used to approach biological queries from an unbiased and untargeted perspective.

Presentation 4: The changing landscape of biotherapeutics: A look at the role of analytical technologies

The characterization of biological products is an important part of the entire biological development pipeline. The landscape of this characterization is ever evolving as new product classes, such as biosimilars or gene/cell therapies, come to the market.

In this webinar, Dr. Jared Auclair will explore the landscape of analytical characterization throughout the life cycle of a drug product, in research and development, process development, quality characterization and more. In particular, Auclair will emphasize the current trends and p

MOBILion Systems